297 related articles for article (PubMed ID: 33609687)
1. TNFα enhances trovafloxacin-induced in vitro hepatotoxicity by inhibiting protective autophagy.
Ahn JH; Jegal H; Choi MS; Kim S; Park SM; Ahn J; Han HY; Cho HS; Yoon S; Oh JH
Toxicol Lett; 2021 May; 342():73-84. PubMed ID: 33609687
[TBL] [Abstract][Full Text] [Related]
2. Trovafloxacin-induced replication stress sensitizes HepG2 cells to tumor necrosis factor-alpha-induced cytotoxicity mediated by extracellular signal-regulated kinase and ataxia telangiectasia and Rad3-related.
Beggs KM; Maiuri AR; Fullerton AM; Poulsen KL; Breier AB; Ganey PE; Roth RA
Toxicology; 2015 May; 331():35-46. PubMed ID: 25748550
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of hepatocellular apoptosis induced by trovafloxacin-tumor necrosis factor-alpha interaction.
Beggs KM; Fullerton AM; Miyakawa K; Ganey PE; Roth RA
Toxicol Sci; 2014 Jan; 137(1):91-101. PubMed ID: 24097668
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor alpha is a proximal mediator of synergistic hepatotoxicity from trovafloxacin/lipopolysaccharide coexposure.
Shaw PJ; Ganey PE; Roth RA
J Pharmacol Exp Ther; 2009 Jan; 328(1):62-8. PubMed ID: 18820134
[TBL] [Abstract][Full Text] [Related]
5. Tissue influx of neutrophils and monocytes is delayed during development of trovafloxacin-induced tumor necrosis factor-dependent liver injury in mice.
Giustarini G; Kruijssen L; van Roest M; Bleumink R; Weaver RJ; Bol-Schoenmakers M; Smit J; Pieters R
J Appl Toxicol; 2018 May; 38(5):753-765. PubMed ID: 29377180
[TBL] [Abstract][Full Text] [Related]
6. The hepatotoxic fluoroquinolone trovafloxacin disturbs TNF- and LPS-induced p65 nuclear translocation in vivo and in vitro.
Giustarini G; Huppelschoten S; Barra M; Oppelt A; Wagenaar L; Weaver RJ; Bol-Schoenmakers M; Smit JJ; van de Water B; Klingmüller U; Pieters RHH
Toxicol Appl Pharmacol; 2020 Mar; 391():114915. PubMed ID: 32035082
[TBL] [Abstract][Full Text] [Related]
7. Comparison of TNFα to lipopolysaccharide as an inflammagen to characterize the idiosyncratic hepatotoxicity potential of drugs: Trovafloxacin as an example.
Liguori MJ; Ditewig AC; Maddox JF; Luyendyk JP; Lehman-McKeeman LD; Nelson DM; Bhaskaran VM; Waring JF; Ganey PE; Roth RA; Blomme EA
Int J Mol Sci; 2010 Nov; 11(11):4697-714. PubMed ID: 21151465
[TBL] [Abstract][Full Text] [Related]
8. Trovafloxacin enhances lipopolysaccharide-stimulated production of tumor necrosis factor-α by macrophages: role of the DNA damage response.
Poulsen KL; Olivero-Verbel J; Beggs KM; Ganey PE; Roth RA
J Pharmacol Exp Ther; 2014 Jul; 350(1):164-70. PubMed ID: 24817034
[TBL] [Abstract][Full Text] [Related]
9. Trovafloxacin-Induced Liver Injury: Lack in Regulation of Inflammation by Inhibition of Nucleotide Release and Neutrophil Movement.
Giustarini G; Vrisekoop N; Kruijssen L; Wagenaar L; van Staveren S; van Roest M; Bleumink R; Bol-Schoenmakers M; Weaver RJ; Koenderman L; Smit J; Pieters R
Toxicol Sci; 2019 Feb; 167(2):385-396. PubMed ID: 30247740
[TBL] [Abstract][Full Text] [Related]
10. Trovafloxacin enhances TNF-induced inflammatory stress and cell death signaling and reduces TNF clearance in a murine model of idiosyncratic hepatotoxicity.
Shaw PJ; Beggs KM; Sparkenbaugh EM; Dugan CM; Ganey PE; Roth RA
Toxicol Sci; 2009 Oct; 111(2):288-301. PubMed ID: 19638433
[TBL] [Abstract][Full Text] [Related]
11. Trovafloxacin potentiation of lipopolysaccharide-induced tumor necrosis factor release from RAW 264.7 cells requires extracellular signal-regulated kinase and c-Jun N-Terminal Kinase.
Poulsen KL; Albee RP; Ganey PE; Roth RA
J Pharmacol Exp Ther; 2014 May; 349(2):185-91. PubMed ID: 24525298
[TBL] [Abstract][Full Text] [Related]
12. Coexposure of mice to trovafloxacin and lipopolysaccharide, a model of idiosyncratic hepatotoxicity, results in a unique gene expression profile and interferon gamma-dependent liver injury.
Shaw PJ; Ditewig AC; Waring JF; Liguori MJ; Blomme EA; Ganey PE; Roth RA
Toxicol Sci; 2009 Jan; 107(1):270-80. PubMed ID: 18930950
[TBL] [Abstract][Full Text] [Related]
13. Implication of hepatic transporters (MDR1 and MRP2) in inflammation-associated idiosyncratic drug-induced hepatotoxicity investigated by microvolume cytometry.
Saab L; Peluso J; Muller CD; Ubeaud-Sequier G
Cytometry A; 2013 Apr; 83(4):403-8. PubMed ID: 23401306
[TBL] [Abstract][Full Text] [Related]
14. Trovafloxacin enhances the inflammatory response to a Gram-negative or a Gram-positive bacterial stimulus, resulting in neutrophil-dependent liver injury in mice.
Shaw PJ; Ganey PE; Roth RA
J Pharmacol Exp Ther; 2009 Jul; 330(1):72-8. PubMed ID: 19351866
[TBL] [Abstract][Full Text] [Related]
15. Microarray analysis of lipopolysaccharide potentiation of trovafloxacin-induced liver injury in rats suggests a role for proinflammatory chemokines and neutrophils.
Waring JF; Liguori MJ; Luyendyk JP; Maddox JF; Ganey PE; Stachlewitz RF; North C; Blomme EA; Roth RA
J Pharmacol Exp Ther; 2006 Mar; 316(3):1080-7. PubMed ID: 16299187
[TBL] [Abstract][Full Text] [Related]
16. The role of the hemostatic system in murine liver injury induced by coexposure to lipopolysaccharide and trovafloxacin, a drug with idiosyncratic liability.
Shaw PJ; Fullerton AM; Scott MA; Ganey PE; Roth RA
Toxicol Appl Pharmacol; 2009 May; 236(3):293-300. PubMed ID: 19367693
[TBL] [Abstract][Full Text] [Related]
17. Lipopolysaccharide and trovafloxacin coexposure in mice causes idiosyncrasy-like liver injury dependent on tumor necrosis factor-alpha.
Shaw PJ; Hopfensperger MJ; Ganey PE; Roth RA
Toxicol Sci; 2007 Nov; 100(1):259-66. PubMed ID: 17709330
[TBL] [Abstract][Full Text] [Related]
18. Natural Cyclopeptide RA-XII, a New Autophagy Inhibitor, Suppresses Protective Autophagy for Enhancing Apoptosis through AMPK/mTOR/P70S6K Pathways in HepG2 Cells.
Song L; Wang Z; Wang Y; Guo D; Yang J; Chen L; Tan N
Molecules; 2017 Nov; 22(11):. PubMed ID: 29137114
[TBL] [Abstract][Full Text] [Related]
19. Inactivated Sendai virus induces apoptosis and autophagy via the PI3K/Akt/mTOR/p70S6K pathway in human non-small cell lung cancer cells.
Zhang Q; Zhu H; Xu X; Li L; Tan H; Cai X
Biochem Biophys Res Commun; 2015 Sep; 465(1):64-70. PubMed ID: 26235873
[TBL] [Abstract][Full Text] [Related]
20. Berberine represses human gastric cancer cell growth in vitro and in vivo by inducing cytostatic autophagy via inhibition of MAPK/mTOR/p70S6K and Akt signaling pathways.
Zhang Q; Wang X; Cao S; Sun Y; He X; Jiang B; Yu Y; Duan J; Qiu F; Kang N
Biomed Pharmacother; 2020 Aug; 128():110245. PubMed ID: 32454290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
